"ギルガメッシュ" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonGilgamesh’s psychedelic touts 94% remission rate in depression study - Clinical Trials Arena
Gilgamesh’s psychedelic touts 94% remission rate in depression study Clinical Trials Arena
AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for M...
AbbVie wagers more than $1B on Gilgamesh’s psychedelic drug - BioPharma Dive
AbbVie wagers more than $1B on Gilgamesh’s psychedelic drug BioPharma Dive
AbbVie to buy Gilgamesh’s psychedelic drug for up to $1.2 billion - statnews.com
AbbVie to buy Gilgamesh’s psychedelic drug for up to $1.2 billion statnews.com
AbbVie signs to acquire Gilgamesh’s bretisilocin for $1.2bn - Pharmaceutical Technology
AbbVie signs to acquire Gilgamesh’s bretisilocin for $1.2bn Pharmaceutical Technology
AbbVie in talks to acquire Gilgamesh Pharmaceuticals, Bloomberg News reports - Reuters
AbbVie in talks to acquire Gilgamesh Pharmaceuticals, Bloomberg News reports Reuters
AbbVie Embraces Psychedelic Drug with Up-to-$1.2B Deal for Gilgamesh’s MDD Candidate - Genetic En...
AbbVie Embraces Psychedelic Drug with Up-to-$1.2B Deal for Gilgamesh’s MDD Candidate Genetic Engineering and Biotechnology News
AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal - Bloomberg.com
AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal Bloomberg.com
Gilgamesh to close flagship southeast Salem restaurant and brew pub - Statesman Journal
Gilgamesh to close flagship southeast Salem restaurant and brew pub Statesman Journal
AbbVie said to be circling $1B takeout of Gilgamesh: report - FirstWord Pharma
AbbVie said to be circling $1B takeout of Gilgamesh: report FirstWord Pharma
AbbVie buying Gilgamesh’s psychedelic therapy, planning spinout: Deals Report - biocentury.com
AbbVie buying Gilgamesh’s psychedelic therapy, planning spinout: Deals Report biocentury.com
AbbVie crowns Gilgamesh its next M&A target with $1B buyout talks: report - Fierce Biotech
AbbVie crowns Gilgamesh its next M&A target with $1B buyout talks: report Fierce Biotech
Unswayed by Cerevel Failure, AbbVie Buys Gilgamesh’s Depression Drug for $1.2B - BioSpace
Unswayed by Cerevel Failure, AbbVie Buys Gilgamesh’s Depression Drug for $1.2B BioSpace
Fintech-focused Gilgamesh Ventures nabs $20m for Fund II - Venture Capital Journal
Fintech-focused Gilgamesh Ventures nabs $20m for Fund II Venture Capital Journal
Pα+ Psychedelic Bulletin #205: AbbVie Eyes Gilgamesh; Psychedelics Use Increases in U.S.; FDA Mov...
Pα+ Psychedelic Bulletin #205: AbbVie Eyes Gilgamesh; Psychedelics Use Increases in U.S.; FDA Moves to Ban Kraton Compound 7-OH; What Is Sinema Selling? Psychedelic Alpha
AbbVie to Acquire Gilgamesh Pharmaceutical’s Psychedelic Drug for $1.2B - Contract Pharma
AbbVie to Acquire Gilgamesh Pharmaceutical’s Psychedelic Drug for $1.2B Contract Pharma
Gilgamesh Pharmaceuticals Announces Positive Topline Phase 2a Results for GM-2505 in Major Depres...
AbbVie tunes in to Gilgamesh's story, inking $1.2B deal for psychedelic program - Fierce Biotech
AbbVie tunes in to Gilgamesh's story, inking $1.2B deal for psychedelic program Fierce Biotech
AbbVie targets psychedelic-based depression drug market with $1.2 billion deal - Reuters
AbbVie targets psychedelic-based depression drug market with $1.2 billion deal Reuters
Gilgamesh links psychedelic to 94% remission rate in midphase depression trial - Fierce Biotech
Gilgamesh links psychedelic to 94% remission rate in midphase depression trial Fierce Biotech
AbbVie in Talks to Buy Gilgamesh Pharmaceuticals for $1 Billion - Yahoo Finance
AbbVie in Talks to Buy Gilgamesh Pharmaceuticals for $1 Billion Yahoo Finance
AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health ...
AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market Yahoo Finance
Fintech venture firm Gilgamesh Ventures raises $20M Fund II - Axios
Fintech venture firm Gilgamesh Ventures raises $20M Fund II Axios
Gilgamesh’s Next-Gen Psychedelic GM-2505 Prints Impressive Results in Phase 2a Major Depressive D...
Gilgamesh’s Next-Gen Psychedelic GM-2505 Prints Impressive Results in Phase 2a Major Depressive Disorder Study Psychedelic Alpha
6 questions for Andrew Endicott of Gilgamesh Ventures - The Financial Revolutionist
6 questions for Andrew Endicott of Gilgamesh Ventures The Financial Revolutionist
AbbVie to Acquire Gilgamesh’s Bretisilocin for Up to $1.2B - Psychedelic Alpha
AbbVie to Acquire Gilgamesh’s Bretisilocin for Up to $1.2B Psychedelic Alpha
AbbVie to buy Gilgamesh drug candidate in $1.2B deal - Axios
AbbVie: H1 2025 Earnings Strengthen Case For Targeting Gilgamesh Acquisition (NYSE:ABBV) - Seekin...
AbbVie: H1 2025 Earnings Strengthen Case For Targeting Gilgamesh Acquisition (NYSE:ABBV) Seeking Alpha
AbbVie acquires Gilgamesh's psychedelic in $1.2bn depression treatment deal - BioXconomy
AbbVie acquires Gilgamesh's psychedelic in $1.2bn depression treatment deal BioXconomy
Gilgamesh joins a second $1B+ deal with Abbvie - BioWorld MedTech
Gilgamesh joins a second $1B+ deal with Abbvie BioWorld MedTech
AbbVie Buys Phase II MDD Candidate From Gilgamesh, But Not The Company - insights.citeline.com
AbbVie Buys Phase II MDD Candidate From Gilgamesh, But Not The Company insights.citeline.com
AbbVie to Buy Gilgamesh Depression Drug for Up to $1.2 Billion - Bloomberg.com
AbbVie to Buy Gilgamesh Depression Drug for Up to $1.2 Billion Bloomberg.com
AbbVie Nabs Depression Drug From Gilgamesh In $1.2B Deal - Law360
AbbVie Nabs Depression Drug From Gilgamesh In $1.2B Deal Law360
Irkalla: Gilgamesh's Dream - TIFF
Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks - MSN
Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks MSN
Assyrian Arts Institute to Present World Premiere of ‘Gilgamesh’ - OperaWire
Assyrian Arts Institute to Present World Premiere of ‘Gilgamesh’ OperaWire
AbbVie to buy Gilgamesh’s depression program for up to $1.2B (ABBV:NYSE) - Seeking Alpha
AbbVie to buy Gilgamesh’s depression program for up to $1.2B (ABBV:NYSE) Seeking Alpha
AbbVie Buys Bretisilocin from Gilgamesh in $1.2B Deal to Expand Depression Drug Pipeline–Another ...
AbbVie Buys Bretisilocin from Gilgamesh in $1.2B Deal to Expand Depression Drug Pipeline–Another Win in the Psychedelic Space? geneonline.com
AbbVie in talks to acquire psychiatric pharma Gilgamesh in $1 billion deal - Crain's Chicago Busi...
AbbVie in talks to acquire psychiatric pharma Gilgamesh in $1 billion deal Crain's Chicago Business
AbbVie to acquire Gilgamesh Pharmaceuticals’ bretisilocin for $1.2 billion - Indian Pharma Post
AbbVie to acquire Gilgamesh Pharmaceuticals’ bretisilocin for $1.2 billion Indian Pharma Post
‘Enkidu’ reinvents the magic of “The Epic of Gilgamesh” centuries later - North by Northwestern
‘Enkidu’ reinvents the magic of “The Epic of Gilgamesh” centuries later North by Northwestern
Auction begins for Gilgamesh Brewing equipment as company downsizes - Statesman Journal
Auction begins for Gilgamesh Brewing equipment as company downsizes Statesman Journal
Review: ‘King Gilgamesh’ makes an epic splash at Soulpepper - NEXT Magazine
Review: ‘King Gilgamesh’ makes an epic splash at Soulpepper NEXT Magazine
AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin in $1.2 Billion Deal - geneonline.com
AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin in $1.2 Billion Deal geneonline.com
AbbVie in talks to buy Gilgamesh Pharma for $1 bln- Bloomberg - Investing.com
AbbVie in talks to buy Gilgamesh Pharma for $1 bln- Bloomberg Investing.com
AbbVie to buy psychedelic drug from partner Gilgamesh - Endpoints News
AbbVie to buy psychedelic drug from partner Gilgamesh Endpoints News
Gilgamesh’s psychedelic drug demonstrates exceptional efficacy for treating depression - Mugglehe...
Gilgamesh’s psychedelic drug demonstrates exceptional efficacy for treating depression Mugglehead Magazine
AbbVie's latest acquisition targets Gilgamesh's psychedelic drug to treat depression - The Busine...
AbbVie's latest acquisition targets Gilgamesh's psychedelic drug to treat depression The Business Journals
AbbVie Seeks To Expand Psychiatry Pipeline By Acquiring Gilgamesh’s Lead Candidate For Up To $1.2...
AbbVie Seeks To Expand Psychiatry Pipeline By Acquiring Gilgamesh’s Lead Candidate For Up To $1.2B Stocktwits
‘The Epic of Gilgamesh’: The First Great Work of Literature - Medium
‘The Epic of Gilgamesh’: The First Great Work of Literature Medium
Review: Irkalla – Gilgamesh’s Dream - Cineuropa
Review: Irkalla – Gilgamesh’s Dream Cineuropa
AbbVie to acquire Gilgamesh Pharma’ mental disorder candidate for $1.2 Bn - ET Pharma
AbbVie to acquire Gilgamesh Pharma’ mental disorder candidate for $1.2 Bn ET Pharma
AbbVie to buy Gilgamesh’s depression program for up to $1.2B - MSN
AbbVie to buy Gilgamesh’s depression program for up to $1.2B MSN
‘Gilgamesh’ made its world premiere - Hürriyet Daily News
‘Gilgamesh’ made its world premiere Hürriyet Daily News
Theater review: Marin native creates fascinating adaptation of ‘Gilgamesh’ - Marin Independent Jo...
Theater review: Marin native creates fascinating adaptation of ‘Gilgamesh’ Marin Independent Journal
Gypsy & the Cat and the ‘Epic of Gilgamesh’ - PopMatters
Gypsy & the Cat and the ‘Epic of Gilgamesh’ PopMatters
AbbVie to Acquire Gilgamesh's Antidepressant Bretisilocin in $1.2 Billion Deal - PharmiWeb.com
AbbVie to Acquire Gilgamesh's Antidepressant Bretisilocin in $1.2 Billion Deal PharmiWeb.com
The Hittite Version of the Epic of Gilgamesh, Discovered on Tablets in Hattusa, Has Differing Str...
The Hittite Version of the Epic of Gilgamesh, Discovered on Tablets in Hattusa, Has Differing Structure and Narrative Details La Brújula Verde
Real-life story behind Fountain Of Youth: From Gilgamesh to Florida, the myth that inspired Guy R...
Real-life story behind Fountain Of Youth: From Gilgamesh to Florida, the myth that inspired Guy Ritchie’s new movie The Indian Express
Irkalla - Gilgamesh's Dream de Mohamed Jabarah Al Daradji (2025) - Unifrance
Irkalla - Gilgamesh's Dream de Mohamed Jabarah Al Daradji (2025) Unifrance
King Gilgamesh Sizzles at Soulpepper Theatre: REVIEW - Torontonicity
King Gilgamesh Sizzles at Soulpepper Theatre: REVIEW Torontonicity
Sumer, which gave us ‘The Epic of Gilgamesh’, rose as a result of rivers, tides and sediments - D...
Sumer, which gave us ‘The Epic of Gilgamesh’, rose as a result of rivers, tides and sediments Down To Earth
Gilgamesh, London: ‘It’s a weird trip’ - restaurant review - The Guardian
Gilgamesh, London: ‘It’s a weird trip’ - restaurant review The Guardian
Screw Sephiroth, Gilgamesh Is Final Fantasy's Greatest Villain - TheGamer
Screw Sephiroth, Gilgamesh Is Final Fantasy's Greatest Villain TheGamer
Gilgamesh Pharmaceuticals Awarded $14 Million National Institute on Drug Abuse Grant to Advance N...
AbbVie inks $2B-plus next-gen neuro deal with Gilgamesh - Fierce Biotech
AbbVie inks $2B-plus next-gen neuro deal with Gilgamesh Fierce Biotech
Gilgamesh Pharmaceuticals Announces AbbVie Collaboration Up to Over $2 Billion - Ropes & Gray LLP
Gilgamesh Pharmaceuticals Announces AbbVie Collaboration Up to Over $2 Billion Ropes & Gray LLP
Gilgamesh to initiate Phase IIa trial of fast-acting psychedelic drug - Clinical Trials Arena
Gilgamesh to initiate Phase IIa trial of fast-acting psychedelic drug Clinical Trials Arena
AbbVie makes a play for psychiatric treatments with $2bn Gilgamesh collaboration - Pharmaceutical...
AbbVie makes a play for psychiatric treatments with $2bn Gilgamesh collaboration Pharmaceutical Technology
Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health Treatments - PR Ne...
Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health Treatments PR Newswire
Ancient Gilgamesh tablet taken from Iraq and bought by Hobby Lobby is returned - NBC News
Ancient Gilgamesh tablet taken from Iraq and bought by Hobby Lobby is returned NBC News
At Gilgamesh, a Taste of Iraq and the Flavors of Home - D Magazine
At Gilgamesh, a Taste of Iraq and the Flavors of Home D Magazine
The epic adventures of the Gilgamesh Dream tablet - BBC
Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round - PR Newswire
Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round PR Newswire
AbbVie wagers up to $2B on Gilgamesh's approach to psychedelics – minus the trip - FirstWord Pharma
AbbVie wagers up to $2B on Gilgamesh's approach to psychedelics – minus the trip FirstWord Pharma
Walking Shadow Theatre – “Gilgamesh” and “Beowulf” - Lavender Magazine
Walking Shadow Theatre – “Gilgamesh” and “Beowulf” Lavender Magazine
Climate Change: From Gilgamesh to Hitchhiker’s Guide to the Galaxy - The Marginalia Review of Books
Climate Change: From Gilgamesh to Hitchhiker’s Guide to the Galaxy The Marginalia Review of Books
TTYL: Glory and Gilgamesh - The Stanford Daily
TTYL: Glory and Gilgamesh The Stanford Daily
KPFA Special: Reading the Epic of Gilgamesh (Part I) - KPFA
Authorities Seek Forfeiture of Ancient Gilgamesh Tablet From Hobby Lobby (Published 2020) - The N...
Authorities Seek Forfeiture of Ancient Gilgamesh Tablet From Hobby Lobby (Published 2020) The New York Times
Getting through hard times with 10 days of 'The Epic of Gilgamesh' - Iowa City Press-Citizen
Getting through hard times with 10 days of 'The Epic of Gilgamesh' Iowa City Press-Citizen
Michael Schmidt on Gilgamesh - Princeton University Press
Michael Schmidt on Gilgamesh Princeton University Press
Gilgamesh is required for the maintenance of germline stem cells in Drosophila testis - Nature
Gilgamesh is required for the maintenance of germline stem cells in Drosophila testis Nature
Gilgamesh tablet: US authorities take ownership of artefact - BBC
Gilgamesh tablet: US authorities take ownership of artefact BBC
Gilgamesh flood tablet: A 2,600-year-old text that's eerily similar to the story of Noah's Ark - ...
Gilgamesh flood tablet: A 2,600-year-old text that's eerily similar to the story of Noah's Ark Live Science
Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD/MAD Clinical Trials of GM-1020 - Psy...
Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD/MAD Clinical Trials of GM-1020 Psychedelic Alpha
Why Gilgamesh failed: the mechanistic basis of the limits to human lifespan - Nature
Why Gilgamesh failed: the mechanistic basis of the limits to human lifespan Nature
Authorities announce forfeiture of ancient Gilgamesh tablet from Hobby Lobby's Museum of the Bibl...
Authorities announce forfeiture of ancient Gilgamesh tablet from Hobby Lobby's Museum of the Bible NBC News
Gilgamesh Brewing Releases Peanut Butter Mint White Chocolate Imperial Stout - New School Beer + ...
Gilgamesh Brewing Releases Peanut Butter Mint White Chocolate Imperial Stout New School Beer + Cider
An ancient clay tablet at Yale has shed light on how the 'Epic of Gilgamesh' has evolved over the...
Gilgamesh Tweaks Known Psychedelics To Improve Therapies - lucid.news
Gilgamesh Tweaks Known Psychedelics To Improve Therapies lucid.news
Banner exhibition graphic works of Harry van Kruiningen about the Epic of Gilgamesh - Universitei...
Banner exhibition graphic works of Harry van Kruiningen about the Epic of Gilgamesh Universiteit Leiden
King Gilgamesh (and the man of the wild) - To Do Canada
King Gilgamesh (and the man of the wild) To Do Canada
Richardson Iraqi restaurant Gilgamesh opens new bakery - Community Impact
Richardson Iraqi restaurant Gilgamesh opens new bakery Community Impact
Looted Gilgamesh tablet, one of world’s oldest surviving works of literature, returns to Iraq - PBS
Looted Gilgamesh tablet, one of world’s oldest surviving works of literature, returns to Iraq PBS
Guide to the classics: the Epic of Gilgamesh - The Conversation
Guide to the classics: the Epic of Gilgamesh The Conversation
SCRUTINY | Soulpepper’s King Gilgamesh & The Man Of The Wild Is Riveting Music & Theatre - ludwig...
SCRUTINY | Soulpepper’s King Gilgamesh & The Man Of The Wild Is Riveting Music & Theatre ludwig-van.com
The Woods, Gilgamesh Brewing's West Salem bar and restaurant is now open - Statesman Journal
The Woods, Gilgamesh Brewing's West Salem bar and restaurant is now open Statesman Journal
Listen to The Epic of Gilgamesh Being Read in its Original Ancient Language, Akkadian - Open Culture
Listen to The Epic of Gilgamesh Being Read in its Original Ancient Language, Akkadian Open Culture
Gilgamesh Pharmaceuticals Awarded $14 Million National Institute on Drug Abuse Grant to Advance N...